CD24 and breast carcinoma: Breast cancer spheroids enriched with CD44+/CD24- cells grew tumors and targeting these CSCs with niclosamide inhibited spheroid formation, induced apoptosis, and inhibited tumor growth in mice (Fig. 5f) [79].